168 related articles for article (PubMed ID: 18506619)
1. Cancer stem/progenitor cell active compound 8-quinolinol in combination with paclitaxel achieves an improved cure of breast cancer in the mouse model.
Zhou J; Zhang H; Gu P; Margolick JB; Yin D; Zhang Y
Breast Cancer Res Treat; 2009 May; 115(2):269-77. PubMed ID: 18506619
[TBL] [Abstract][Full Text] [Related]
2. NF-kappaB pathway inhibitors preferentially inhibit breast cancer stem-like cells.
Zhou J; Zhang H; Gu P; Bai J; Margolick JB; Zhang Y
Breast Cancer Res Treat; 2008 Oct; 111(3):419-27. PubMed ID: 17965935
[TBL] [Abstract][Full Text] [Related]
3. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy.
Fillmore CM; Kuperwasser C
Breast Cancer Res; 2008; 10(2):R25. PubMed ID: 18366788
[TBL] [Abstract][Full Text] [Related]
4. The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles.
Zhang Y; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
Biomaterials; 2012 Jan; 33(2):679-91. PubMed ID: 22019123
[TBL] [Abstract][Full Text] [Related]
5. Autophagy of cancer stem cells is involved with chemoresistance of colon cancer cells.
Wu S; Wang X; Chen J; Chen Y
Biochem Biophys Res Commun; 2013 May; 434(4):898-903. PubMed ID: 23624503
[TBL] [Abstract][Full Text] [Related]
6. ShRNA targeting Notch1 sensitizes breast cancer stem cell to paclitaxel.
Mao J; Song B; Shi Y; Wang B; Fan S; Yu X; Tang J; Li L
Int J Biochem Cell Biol; 2013 Jun; 45(6):1064-73. PubMed ID: 23500524
[TBL] [Abstract][Full Text] [Related]
7. Targeting CXCR1 on breast cancer stem cells: signaling pathways and clinical application modelling.
Brandolini L; Cristiano L; Fidoamore A; De Pizzol M; Di Giacomo E; Florio TM; Confalone G; Galante A; Cinque B; Benedetti E; Ruffini PA; Cifone MG; Giordano A; Alecci M; Allegretti M; Cimini A
Oncotarget; 2015 Dec; 6(41):43375-94. PubMed ID: 26517518
[TBL] [Abstract][Full Text] [Related]
8. [Effect of down-regulation of Oct4 gene on biological characteristics of MDA-MB-231 breast cancer stem cells].
Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):251-7. PubMed ID: 26462888
[TBL] [Abstract][Full Text] [Related]
9. Selectively Targeting Breast Cancer Stem Cells by 8-Quinolinol and Niclosamide.
Cámara-Sánchez P; Díaz-Riascos ZV; García-Aranda N; Gener P; Seras-Franzoso J; Giani-Alonso M; Royo M; Vázquez E; Schwartz S; Abasolo I
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233074
[TBL] [Abstract][Full Text] [Related]
10. HER2 decreases drug sensitivity of ovarian cancer cells via inducing stem cell-like property in an NFκB-dependent way.
Wang W; Gao Y; Hai J; Yang J; Duan S
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30314995
[TBL] [Abstract][Full Text] [Related]
11. A potential target associated with both cancer and cancer stem cells: a combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes.
Liu Y; Lu WL; Guo J; Du J; Li T; Wu JW; Wang GL; Wang JC; Zhang X; Zhang Q
J Control Release; 2008 Jul; 129(1):18-25. PubMed ID: 18466993
[TBL] [Abstract][Full Text] [Related]
12. A High-Throughput Image Cytometry Method for the Formation, Morphometric, and Viability Analysis of Drug-Treated Mammospheres.
Kessel SL; Chan LL
SLAS Discov; 2020 Aug; 25(7):723-733. PubMed ID: 32396489
[TBL] [Abstract][Full Text] [Related]
13. Machilin D, a Lignin Derived from Saururus chinensis, Suppresses Breast Cancer Stem Cells and Inhibits NF-κB Signaling.
Zhen X; Choi HS; Kim JH; Kim SL; Liu R; Yun BS; Lee DS
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32033472
[TBL] [Abstract][Full Text] [Related]
14. Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas.
Elkashty OA; Abu Elghanam G; Su X; Liu Y; Chauvin PJ; Tran SD
Carcinogenesis; 2020 Jun; 41(4):458-466. PubMed ID: 31742606
[TBL] [Abstract][Full Text] [Related]
15. DNA methyltransferase inhibitor CDA-2 synergizes with high-dose thiotepa and paclitaxel in killing breast cancer stem cells.
Lu Z; Jia J; Di L; Song G; Yuan Y; Ma B; Yu J; Zhu Y; Wang X; Zhou X; Ren J
Front Biosci (Elite Ed); 2011 Jan; 3(1):240-9. PubMed ID: 21196304
[TBL] [Abstract][Full Text] [Related]
16. Cardamonin reduces chemotherapy-enriched breast cancer stem-like cells in vitro and in vivo.
Jia D; Tan Y; Liu H; Ooi S; Li L; Wright K; Bennett S; Addison CL; Wang L
Oncotarget; 2016 Jan; 7(1):771-85. PubMed ID: 26506421
[TBL] [Abstract][Full Text] [Related]
17. Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models.
Urbaniak A; Reed MR; Fil D; Moorjani A; Heflin S; Antoszczak M; Sulik M; Huczyński A; Kupsik M; Eoff RL; MacNicol MC; Chambers TC; MacNicol AM
Biomed Pharmacother; 2021 Sep; 141():111815. PubMed ID: 34130123
[TBL] [Abstract][Full Text] [Related]
18. Effects of stealth liposomal daunorubicin plus tamoxifen on the breast cancer and cancer stem cells.
Guo J; Zhou J; Ying X; Men Y; Li RJ; Zhang Y; Du J; Tian W; Yao HJ; Wang XX; Ju RJ; Lu WL
J Pharm Pharm Sci; 2010; 13(2):136-51. PubMed ID: 20816001
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of cancer stem-like cells from primary carcinoma of the cervix uteri.
Feng D; Peng C; Li C; Zhou Y; Li M; Ling B; Wei H; Tian Z
Oncol Rep; 2009 Nov; 22(5):1129-34. PubMed ID: 19787230
[TBL] [Abstract][Full Text] [Related]
20. Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission.
Hirsch HA; Iliopoulos D; Tsichlis PN; Struhl K
Cancer Res; 2009 Oct; 69(19):7507-11. PubMed ID: 19752085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
